Completed OBSERVATIONAL NCT04072250

Surgery for Recurrent Intrahepatic Cholangiocarcinoma

Surgery for Recurrent Intrahepatic Cholangiocarcinoma: a Promise or an Excess?

Sponsor: Chang Gung Memorial Hospital

Conditions Cholangiocarcinoma, Intrahepatic Re-hepatectomy Recurrence Cholangiocarcinoma

Interventions hepatectomy

Updated 6 times since 2019 Last updated: Sep 11, 2019 Started: Jun 1, 2017 Primary completion: Oct 1, 2018 Completion: Oct 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04072250, this observational or N/A phase trial focuses on Cholangiocarcinoma, Intrahepatic and Re-hepatectomy and remains completed. Sponsored by Chang Gung Memorial Hospital, it has been updated 6 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Oct 2019 — Jan 2021 [monthly]

Completed

▶ Show 1 earlier version

Sep 2019 — Oct 2019 [monthly]

Completed

First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chang Gung Memorial Hospital

Data source: Chang Gung Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taoyuan District, Taiwan